A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)
Clinical trial NCT01192906 · COMPLETED
Trial details
- NCT number
- NCT01192906
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2014-07-01
- Enrollment
- 624
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.